EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

BACKGROUND: Ephrin receptors (Eph) and their ligands, called ephrins, function in various disease processes. However, the expression level and prognostic value of Eph/ephrins in lung adenocarcinoma (LUAD) are still unclear. METHODS: The Oncomine and GEPIA databases were used to explore the different...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Mingming, Tong, Run, Zhang, Zhe, Wang, Tao, Liang, Chaonan, Zhou, Xiaoming, Hou, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513303/
https://www.ncbi.nlm.nih.gov/pubmed/34645436
http://dx.doi.org/10.1186/s12935-021-02226-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513303/
https://www.ncbi.nlm.nih.gov/pubmed/34645436
http://dx.doi.org/10.1186/s12935-021-02226-x

Ejemplares similares